Estudio coste-efectividad de la estrategia empírica antifúngica en pacientes oncohematológicos

The analysis provides relevant information from the perspective of clinical practice in spite of the limitations of the unconsidered costs (nephrotoxicity). This type of analysis contributes to rationalizing the use of antifungal agents in the hospital setting and in high-risk patients such as oncohaematological ones.